Bioinfi

Bioinformatics and Computational Biology are a critical part of drug discovery and development. Yet, the biotechnology and pharmaceutical industry face significant challenges designing the right informatics experiments to maximize the value of the discovery pipeline, as well as finding the strategic talent to execute those. BioInfi would be delighted to partner with your internal bioinformatics organization and your senior management to provide a single point interface for your bioinformatics strategy and solutions. Our projects have spanned target identification, validation, pharmacodynamic/prognostic/response biomarkers, repurposing, genetics, genomics, chemogenomics, gene-editing, single cell, clinical trial analysis, adverse events, and claims data. Our technical skills span the whole range of computational biology. Also our deep and broad connections with top bioinformatics academic experts enable us to obtain guidance on your projects from top expert labs. We have led computational repurposing experiments with experimental validation for rheumatoid arthritis, inflammatory bowel disease (Crohn's and ulcerative colitis), psoriasis, atopic dermatitis, asthma, COPD, neurosciences (ALS & MS), NASH, rare diseases, and cancer. We have identified numerous small molecule, antibody, RNAi and gene therapy targets across a wide variety of diseases including obesity, diabetes, cardiovascular diseases, infectious diseases, Alzheimers disease, as well as for diseases mentioned for repurposing above. We are also able to assess and partner with the best-in-class bioinformatics vendors.